Albuterol and ipratropium inhalation and Solriamfetol Hydrochloride
Determining the interaction of Albuterol and ipratropium inhalation and Solriamfetol Hydrochloride and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Additive or synergistic effects on blood pressure and/or heart rate may occur when solriamfetol is combined with other drugs that increase blood pressure and/or heart rate. The use of solriamfetol alone has been associated with dose-dependent increases in blood pressure and heart rate. Combined use of solriamfetol with other drugs that increase blood pressure and/or heart rate has not been studied. MANAGEMENT: Caution is advised if solriamfetol is used with other drugs that increase blood pressure and/or heart rate. Blood pressure should be monitored prior to initiating solriamfetol therapy and regularly during treatment. In addition, hypertension should be controlled prior to treatment, and any new-onset hypertension or exacerbations of pre-existing hypertension that occur during solriamfetol therapy should be treated. Discontinuation of solriamfetol should be considered in patients who experience an increase in blood pressure or heart rate that cannot be managed with dose reduction of solriamfetol or other appropriate medical intervention. References "Product Information. Sunosi (solriamfetol)." Jazz Pharmaceuticals, Palo Alto, CA.
Professional:MONITOR: Additive or synergistic effects on blood pressure and/or heart rate may occur when solriamfetol is combined with other drugs that increase blood pressure and/or heart rate. The use of solriamfetol alone has been associated with dose-dependent increases in blood pressure and heart rate. Combined use of solriamfetol with other drugs that increase blood pressure and/or heart rate has not been studied.
MANAGEMENT: Caution is advised if solriamfetol is used with other drugs that increase blood pressure and/or heart rate. Blood pressure should be monitored prior to initiating solriamfetol therapy and regularly during treatment. In addition, hypertension should be controlled prior to treatment, and any new-onset hypertension or exacerbations of pre-existing hypertension that occur during solriamfetol therapy should be treated. Discontinuation of solriamfetol should be considered in patients who experience an increase in blood pressure or heart rate that cannot be managed with dose reduction of solriamfetol or other appropriate medical intervention.
- "Product Information. Sunosi (solriamfetol)." Jazz Pharmaceuticals, Palo Alto, CA.
Generic Name: albuterol / ipratropium
Brand name: Combivent Respimat, DuoNeb, Combivent
Synonyms: Albuterol and ipratropium (inhalation), Ipratropium and Albuterol
Generic Name: solriamfetol
Brand name: Sunosi
Synonyms: Solriamfetol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Albuterol and ipratropium inhalation-Soltamox
- Albuterol and ipratropium inhalation-Solu-Cortef
- Albuterol and ipratropium inhalation-Solu-CORTEF injection
- Albuterol and ipratropium inhalation-Solu-Medrol
- Albuterol and ipratropium inhalation-Solu-MEDROL injection
- Albuterol and ipratropium inhalation-SoluCLENZ Rx
- Solriamfetol Hydrochloride-Albuterol Digital Inhalation Powder
- Solriamfetol Hydrochloride-Albuterol Extended-Release Tablets
- Solriamfetol Hydrochloride-Albuterol Inhalation
- Solriamfetol Hydrochloride-Albuterol Inhalation Aerosol
- Solriamfetol Hydrochloride-Albuterol Inhalation Powder
- Solriamfetol Hydrochloride-Albuterol Inhalation Solution